In recent work of Liu et al. (2018) it was demonstrated that gene transfer of modified CaM prolonged refractoriness of RyR2-mediated SR Ca2+ release, abolishing ventricular arrhythmias observed in a mouse model of CPVT. This evidence concerns the gene RYR2 and catecholaminergic polymorphic ventricular tachycardia.